切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2023, Vol. 17 ›› Issue (01) : 7 -10. doi: 10.3877/cma.j.issn.1674-3253.2023.01.002

临床研究

腹腔镜下腹膜外膀胱根治和原位新膀胱术的初步体会
彭龙飞1, 汪鑫1, 夏典1, 颜松柏1, 王进有1, 毕良宽2,()   
  1. 1. 230601 合肥,安徽医科大学第二附属医院泌尿外科
    2. 518000 深圳,北京大学深圳医院泌尿外科
  • 收稿日期:2022-08-15 出版日期:2023-02-01
  • 通信作者: 毕良宽
  • 基金资助:
    安徽医科大学第二附属医院临床培育计划(2021LCZD04); 安徽医科大学校科研基金(2021xkj051,2021xkj164)

Preliminary experiences of laparoscopic extraperitoneal radical cystectomy with orthotopic ileal neobladder

Longfei Peng1, Xin Wang1, Dian Xia1, Songbai Yan1, Jinyou Wang1, Liangkuan Bi2,()   

  1. 1. Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
    2. Department of Urology, Peking University Shenzhen Hospital, Shenzhen 518000, China
  • Received:2022-08-15 Published:2023-02-01
  • Corresponding author: Liangkuan Bi
引用本文:

彭龙飞, 汪鑫, 夏典, 颜松柏, 王进有, 毕良宽. 腹腔镜下腹膜外膀胱根治和原位新膀胱术的初步体会[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 7-10.

Longfei Peng, Xin Wang, Dian Xia, Songbai Yan, Jinyou Wang, Liangkuan Bi. Preliminary experiences of laparoscopic extraperitoneal radical cystectomy with orthotopic ileal neobladder[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(01): 7-10.

目的

评估腹腔镜腹膜外全膀胱切除和原位新膀胱术的安全性及疗效。

方法

回顾性分析安徽医科大学第二附属医院2021年3月至2022年2月行腹腔镜腹膜外全膀胱切除和原位新膀胱术的8例膀胱癌患者,收集患者的基本资料、手术相关数据及术后随访相关情况。

结果

所有患者均顺利完成手术,年龄为[65(40~78)]岁,BMI为[23.85(19.59~29.07)]kg/m2,手术时间为[280.5(235.0~366.0)]min,术中出血量为[100(50~200)]ml,通气时间为[3(2~4)]d,术后住院时间为[11.5(10.0~20.0)]d,淋巴结清扫数目为[13.5(8.0~29.0)]枚。术后分别有一例患者出现切口愈合不良和漏尿。6例患者进行了术前新辅助治疗,其中2例患者术后病理为T0期。中位随访时间为11个月,其中1例出现骨转移,1例出现泌尿道感染,1例出现肾积水。

结论

腹腔镜下腹膜外全膀胱切除及原位新膀胱术是安全可行的,因其极大程度地保留了腹膜的完整性及避免长时间经腹腔操作对肠道造成干扰,有利于减少肠道并发症,缩短住院时间,值得临床推广。

Objective

To evaluate the safety and efficacy of laparoscopic extraperitoneal radical cystectomy with orthotopic ileal neobladder.

Methods

A retrospective analysis was performed on 8 patients with bladder cancer who underwent laparoscopic extraperitoneal radical cystectomy with orthotopic ileal neobladder in The Second Affiliated Hospital of Anhui Medical University from March 2021 to February 2022. The basic data, operative data and postoperative follow-up data of the patients were collected.

Results

All patients had successful operations. The average age of all patients was [65(40-78)] years, BMI was [23.85(19.59-29.0)] kg/m2, operation time was [280.5(235.0-366.0)] min, intraoperative blood loss was [100(50-200)] ml, ventilation time was [3(2-4)] d, postoperative hospital stay was[11.5(10.0-20.0)] d, and the number of lymph nodes dissected was [13.5(8.0-29.0)]. Among them, one patient had poor incision healing and another had urine leakage. Six patients received preoperative neoadjuvant therapy, and 2 of them had postoperative pathology at T0 stage. The median follow-up time was 11 months, including 1 case with bone metastasis, 1 case with urinary tract infection, and 1 case with hydronephrosis.

Conclusions

Laparoscopic extraperitoneal radical cystectomy with orthotopic ileal neobladder is safe and feasible. Because the peritoneal integrity is retained to a great extent and the interference of intestinal tract is avoided through peritoneal operation for a long time, it is beneficial to reduce intestinal complications and shorten the length of hospital stay, which is worthy of clinical promotion.

表1 八例膀胱癌患者基本资料
表2 八例膀胱癌患者术中及术后情况
[1]
Safiri S, Kolahi AA, Naghavi M. Global Burden of Disease Bladder Cancer Collaborators. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019. BMJ Glob Health. 2021, 6(11): e004128.
[2]
Tong S, Yang Z, Zu X, et al. Anterior versus posterior approach laparoscopic radical cystectomy: a retrospective analysis. World J Surg Oncol. 2019, 17(1): 9.
[3]
Kulkarni JN, Agarwal H. Transperitoneal vs. extraperitoneal radical cystectomy for bladder cancer: A retrospective study. Int Braz J Urol. 2018, 44(2): 296-303.
[4]
毕良宽, 丁德茂, 王进有, 等. 外侧入路三层面法在腹腔镜盆腔淋巴清扫中的应用[J]. 中山大学学报(医学科学版), 2018, 39(3): 463-466.
[5]
刘天琦, 张振辉, 刘豪圣等. 腹腔镜下膀胱癌根治术中完全腹膜外经皮输尿管造口术[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(2): 169-172.
[6]
董兴, 陈继峰. 膀胱癌诊疗的研究进展[J]. 中外医学研究, 2022, 20(03): 177-181.
[7]
徐刚, 潘寿华, 章小龙, 等. 腹腔镜下经腹膜外入路膀胱癌根治术的初步体会[J]. 中国内镜杂志, 2021, 27(4): 58-62.
[8]
Tang K, Li H, Xia D, et al. Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies. PLoS One, 2014, 9(5): e95667.
[9]
夏典, 杨超, 刘昆, 等. 盆腔侧腹膜重建在腹腔镜膀胱根治性切除尿流改道术中的应用[J]. 中国微创外科杂志, 2021, 21(11): 992-996.
[10]
Kulkarni JN, Gulla RI, Tongaonkar HB, et al. Radical cystoprostatectomy: an extraperitoneal retrograde approach. J Urol. 1999, 161(2): 545-548.
[11]
Zhang Y, Zhou H, Tuo ZT, et al. Extraperitoneal laparoscopic radical cystectomy with intracorporeal neobladder: a comparison with transperitoneal approach. World J Surg Oncol, 2022, 20(1): 130.
[12]
Feng L, Song J, Wu M, et al. Extraperitoneal versus transperitoneal laparoscopic radical cystectomy for selected elderly bladder cancer patients: a single center experience. Int Braz J Urol, 2016, 42(4): 655-662.
[13]
张宗亮, 种丽强, 赵凯, 等. 加速康复外科下经腹膜外3D腹腔镜膀胱全切回肠原位新膀胱术探索("大家泌尿网"观看手术视频)[J]. 现代泌尿外科杂志, 2020, 25(7): 565-569.
[14]
Zhu YP, Ye DW, Yao XD, et al. Defining good candidates for extraperitoneal cystectomy: results from random peritoneum biopsies of 136 cases. Urology, 2013, 81(4): 820-824.
[15]
施鸿金, 范志楠, 阳晶, 等. 免疫检查点抑制剂在肌层浸润性膀胱癌新辅助免疫治疗中的应用研究进展[J].山东医药, 2022, 62(6): 86-90.
[1] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[2] 高建新, 王啸飞, 于淼, 路夷平. 局部进展期直肠癌新辅助治疗后行ISR术远切缘距离的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 539-543.
[3] 李阳, 董峰, 曾立鹏. 局部进展期直肠癌新辅助治疗后腹腔镜TaTME与TME中的对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 547-550.
[4] 王东阳, 林琳, 娄熙彬. SII对局部进展期胃癌nCRT+腹腔镜胃癌根治术后并发症及预后的影响研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 315-318.
[5] 李娇娇, 张军, 徐顺. 全程新辅助治疗联合全直肠系膜切除术对局部进展期直肠癌预后的影响研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 283-286.
[6] 庞名扬, 魏勇, 沈露明, 朱清毅. 运用国产单孔机器人完成经膀胱入路膀胱部分切除术治疗膀胱癌一例报道[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 638-643.
[7] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[8] 刘中文, 刘畅, 高洋, 刘东, 林世庆, 杨建华, 赵福义. 尿液microRNA-326与腹腔镜根治性膀胱切除术治疗膀胱癌患者预后的相关性研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 386-391.
[9] 魏微阳, 杨浩, 周川鹏, 王奇, 黄红星, 黄亚强. 纤维蛋白原与白蛋白比值及其列线图模型对非肌层浸润性膀胱癌患者电切术后复发的预测价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 243-248.
[10] 刘一鸣, 温佳新, 赵恺, 薛志强. ⅢA 期肺腺癌新辅助治疗后胸腔镜右肺中下叶切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 311-313.
[11] 周倜, 吴嘉, 韩方, 徐林伟, 张宇华. 新辅助治疗时代胰腺癌淋巴结清扫研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 634-639.
[12] 李永政, 孟煜凡, 樊知遥, 展翰翔. 胰腺神经内分泌肿瘤新辅助治疗研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 481-486.
[13] 中国抗癌协会结直肠肿瘤整合康复专业委员会, 北京癌症防治学会直肠癌新辅助治疗专业委员会. 直肠癌新辅助治疗相关恶心、呕吐副反应的预防、诊断及治疗指南[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 353-361.
[14] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?